Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Evotec SE (EVO) Receivables (2020 - 2025)

Evotec SE (EVO) has disclosed Receivables for 6 consecutive years, with $158.7 million as the latest value for Q4 2025.

  • Quarterly Receivables rose 27.44% to $158.7 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $158.7 million through Dec 2025, up 27.44% year-over-year, with the annual reading at $158.7 million for FY2025, 27.44% up from the prior year.
  • Receivables hit $158.7 million in Q4 2025 for Evotec SE, up from $124.5 million in the prior quarter.
  • In the past five years, Receivables ranged from a high of $179.4 million in Q4 2022 to a low of $108.2 million in Q4 2023.
  • Historically, Receivables has averaged $145.0 million across 5 years, with a median of $154.1 million in 2021.
  • Biggest five-year swings in Receivables: surged 51.29% in 2021 and later tumbled 39.7% in 2023.
  • Year by year, Receivables stood at $154.1 million in 2021, then increased by 16.42% to $179.4 million in 2022, then plummeted by 39.7% to $108.2 million in 2023, then increased by 15.09% to $124.5 million in 2024, then grew by 27.44% to $158.7 million in 2025.
  • Business Quant data shows Receivables for EVO at $158.7 million in Q4 2025, $124.5 million in Q4 2024, and $108.2 million in Q4 2023.